Markets Stocks Economy Crypto Earnings Banking Energy
Home› Stocks› Feature
Stocks · Exclusive

Big Caring's IPO gets banking backstop from Maybank, RHB, AmInvestment

Big Caring's IPO gets banking backstop from Maybank, RHB, AmInvestment
Stocks · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Oct 14, 2026 4 min read

Big Caring Group, Malaysia's largest pharmacy chain operator, has taken a significant step toward its planned initial public offering (IPO) by signing retail underwriting agreements with three major banks. Maybank Investment Bank, RHB Investment Bank, and AmInvestment Bank will jointly underwrite 267.6 million shares designated for retail investors.

Retail underwriting is a crucial but often overlooked part of the IPO process. It acts as a safety net, guaranteeing that the shares offered to the public will be sold even if demand falls short. This backing gives the company and its institutional investors confidence that the listing will proceed smoothly, regardless of market conditions.

What is Big Caring Group?

Big Caring Group operates a vast network of pharmacies across Malaysia, making it the country's biggest player in the retail pharmacy space. The company has been expanding its footprint and has seen strong financial growth in recent years. According to its April prospectus, profit after tax surged to 231.8 million ringgit in fiscal 2026, up from just 41.2 million ringgit in fiscal 2023—a more than fivefold increase.

The company plans to sell up to 1.9 billion shares, representing roughly a 25.5% stake in the business. The IPO proceeds are earmarked for expansion and other corporate purposes, though specific allocations were not detailed in the brief.

Why the banking backstop matters

Underwriting agreements are standard practice for IPOs, especially for the retail tranche. They ensure that the public offering is fully subscribed, protecting the issuer from the risk of unsold shares. For Big Caring, having three reputable banks on board signals institutional confidence in the deal.

This move comes at a time when Malaysian stocks have been gaining momentum, partly driven by an improved economic outlook. The International Monetary Fund recently lifted its 2026 growth forecast for the country to 5.2%, which could bode well for new listings.

What it means for investors

For everyday investors, the retail underwriting is a positive sign. It means that the shares set aside for public investors are backed by major banks, reducing the risk of a failed offering. However, it does not guarantee that the stock will rise after listing—investors should still assess the company's fundamentals and valuation.

Big Caring's strong profit growth is notable, but investors should consider whether that growth is sustainable. The pharmacy sector in Malaysia is competitive, and the company's expansion plans will require careful execution. As with any IPO, there are risks, including market volatility and sector-specific challenges.

The involvement of Maybank, RHB, and AmInvestment also adds credibility. These are among the largest financial institutions in Malaysia, and their willingness to underwrite suggests they have confidence in the deal's success.

Broader IPO landscape

Big Caring's IPO is part of a broader trend of companies seeking public listings across Asia. From Hyundai's massive India bet to Dangote Refinery's record-breaking push in Africa, capital markets are active. In Malaysia, the government has been encouraging more listings to deepen the stock market and attract foreign investment.

For investors, IPOs offer a chance to get in early on a company's growth story. But they also come with uncertainty. The retail underwriting provides a measure of safety, but it is not a guarantee of returns. Investors should read the prospectus carefully and consider their own risk tolerance.

Looking ahead

The next milestone for Big Caring will be the official listing date, which has not yet been announced. Investors will be watching for the final pricing and the level of demand from institutional investors. If the retail tranche is oversubscribed, it could indicate strong market appetite.

In the meantime, the banking backstop gives the IPO a solid foundation. For a company that has grown profits fivefold in three years, the listing could be a landmark event for Malaysia's retail pharmacy sector. But as always, the proof will be in the post-listing performance.

More from this story

Next article · Don't miss

SIDBI's 8% bond sale signals investors expect more RBI rate hikes

State-run lender SIDBI sold bonds at an 8.05% coupon, the first time it has paid above 8% in almost a decade. The move reflects investor expectations of more RBI rate hikes and higher borrowing costs across India.

Read the story →
SIDBI's 8% bond sale signals investors expect more RBI rate hikes